Moshe Arditi Selected Research

SARS-CoV spike glycoprotein

1/2021	SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus.
10/2020	Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moshe Arditi Research Topics

Disease

22	Infections 01/2022 - 02/2002
22	Atherosclerosis 06/2020 - 02/2002
21	Inflammation (Inflammations) 10/2021 - 02/2002
15	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022 - 02/2013
14	COVID-19 01/2022 - 05/2020
14	Vasculitis (Vasculitides) 01/2022 - 08/2012
5	Pneumonia (Pneumonitis) 01/2021 - 04/2009
5	Septic Shock (Toxic Shock Syndrome) 01/2021 - 05/2020
5	Neoplasms (Cancer) 01/2020 - 01/2009
4	Arteritis 01/2021 - 11/2005
4	COVID-19 related pediatric multisystem inflammatory disease 01/2021 - 11/2020
4	Cytokine Release Syndrome 01/2021 - 05/2020
4	Aneurysm (Aneurysms) 01/2021 - 01/2016
4	Acute Lung Injury 01/2020 - 02/2014
4	Hypoxia (Hypoxemia) 01/2020 - 02/2014
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 02/2014
3	Fever (Fevers) 01/2021 - 08/2015
3	Ventilator-Induced Lung Injury 01/2020 - 01/2015
3	Chlamydophila Infections 01/2019 - 11/2010
3	Demyelinating Diseases (Demyelinating Disease) 05/2017 - 02/2011
3	Myocardial Infarction 01/2017 - 08/2015
3	Atherosclerotic Plaque (Atheroma) 09/2016 - 02/2002
3	Bacterial Infections (Bacterial Infection) 11/2015 - 08/2003
3	Colitis 09/2010 - 05/2005
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2007 - 04/2004
2	Hypertension (High Blood Pressure) 01/2022 - 12/2021
2	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 01/2020
2	Aortitis 01/2021 - 02/2017
2	Fibrosis (Cirrhosis) 01/2021 - 02/2019
2	Common Cold 01/2021 - 11/2020
2	Bites and Stings (Sting) 01/2020 - 01/2020
2	Hyperlipidemias (Hyperlipidemia) 01/2019 - 01/2018
2	Heart Diseases (Heart Disease) 01/2019 - 01/2016
2	MYD88 Deficiency 10/2018 - 09/2008
2	Hyperplasia 03/2015 - 02/2015
2	Meningitis 01/2013 - 09/2005
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2012 - 01/2011
2	Tuberculosis (Tuberculoses) 06/2005 - 02/2003
1	Hepatitis 01/2022

Drug/Important Bio-Agent (IBA)

17	InflammasomesIBA 10/2021 - 01/2011
13	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013 - 06/2002
12	CytokinesIBA 12/2015 - 06/2002
9	Interleukin-1 (Interleukin 1)IBA 01/2021 - 08/2003
8	SuperantigensIBA 01/2022 - 05/2020
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
7	LipidsIBA 06/2020 - 07/2004
5	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021 - 02/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2011
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2008
5	LDL Receptors (LDL Receptor)IBA 06/2020 - 01/2009
5	LipopolysaccharidesIBA 01/2020 - 08/2003
5	Toll-Like Receptor 4IBA 10/2018 - 07/2004
5	ApolipoproteinsIBA 02/2015 - 07/2004
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2006
4	VaccinesIBA 12/2021 - 02/2015
4	Adenosine Triphosphate (ATP)IBA 01/2021 - 03/2012
4	InterleukinsIBA 01/2020 - 04/2011
4	Interleukin-12 Subunit p40IBA 05/2017 - 11/2008
4	Apolipoproteins E (ApoE)IBA 03/2015 - 11/2008
4	LigandsIBA 01/2009 - 02/2003
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
3	AntigensIBA 12/2021 - 09/2008
3	Neutralizing AntibodiesIBA 01/2021 - 03/2015
3	Monoclonal AntibodiesIBA 01/2021 - 02/2017
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 01/2019
3	InterferonsIBA 01/2020 - 08/2012
3	Myeloid Differentiation Factor 88IBA 10/2018 - 07/2004
3	Interleukin-17 (Interleukin 17)IBA 11/2015 - 01/2010
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 02/2014 - 01/2011
3	Immunoglobulins (Immunoglobulin)IBA 01/2011 - 09/2008
2	staphylococcal enterotoxin BIBA 01/2021 - 11/2020
2	SARS-CoV-2 spike proteinIBA 01/2021 - 11/2020
2	FurinIBA 01/2021 - 11/2020
2	SARS-CoV spike glycoproteinIBA 01/2021 - 10/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2020 - 05/2020
2	Testosterone (Sustanon)FDA Link 06/2020 - 01/2020
2	Interferon Type IIBA 01/2020 - 01/2020
2	Peptidoglycan (Murein)IBA 10/2017 - 02/2003
2	Interleukin-12 Subunit p35IBA 05/2017 - 04/2011
2	Interleukin-2 (IL2)IBA 05/2017 - 02/2011
2	Interleukin-12 (IL 12)IBA 05/2017 - 07/2004
2	Phenobarbital (Luminal)FDA Link 02/2017 - 05/2005
2	Lipoproteins (Lipoprotein)IBA 01/2017 - 05/2006
2	Mitochondrial DNA (mtDNA)IBA 09/2016 - 03/2012
2	Leucine (L-Leucine)FDA Link 09/2016 - 02/2014
2	NucleotidesIBA 09/2016 - 02/2014
2	EnzymesIBA 01/2015 - 01/2012
2	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2015 - 01/2015
2	CholesterolIBA 01/2014 - 11/2010
2	Biological ProductsIBA 02/2013 - 01/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 11/2008
2	Toll-Like Receptor 2IBA 09/2010 - 01/2009
2	Chaperonin 60IBA 07/2009 - 02/2002
2	NF-kappa B (NF-kB)IBA 06/2005 - 02/2002
1	BNT162 VaccineIBA 01/2022
1	EndoribonucleasesIBA 01/2022
1	AutoantigensIBA 12/2021

Therapy/Procedure

9	Therapeutics 01/2021 - 01/2009
3	Artificial Respiration (Mechanical Ventilation) 01/2020 - 02/2014
2	Intraperitoneal Injections 01/2021 - 11/2005